Publication Cover
Advances in Mental Health
Promotion, Prevention and Early Intervention
Volume 14, 2016 - Issue 1
532
Views
15
CrossRef citations to date
0
Altmetric
Articles

Australian mental health staff response to antipsychotic medication side effects – the perceptions of consumers

, &
Pages 4-13 | Received 03 Dec 2014, Accepted 05 Aug 2015, Published online: 04 Sep 2015

References

  • Allen, M. H., Carpenter, D., Sheets, J. L., Miccio, S., & Ross, R. (2003).What do consumers say they want and need during a psychiatric emergency? Journal of Psychiatric Practice, 9, 39–58. doi: 10.1097/00131746-200301000-00005
  • Australian Health Ministers. (1998). Second national mental health plan. Canberra: Commonwealth Department of Health and Family Services.
  • Australian Health Ministers. (2003). National mental health plan 2003–2008. Canberra: Australian Government.
  • Australian Human Rights Commission. (1993). National inquiry concerning the human rights of people with mental illness. Canberra: Australian Government Publishing Service.
  • Barr, J., & Threlkeld, A. J. (2000). Patient--practitioner collaboration in clinical decision-making. Physiotherapy Research International, 5, 254–260. doi: 10.1002/pri.206
  • Bentall, R. P. (2010). Doctoring the mind: Why psychiatric treatments fail. London: Penguin.
  • Berg, B. (2009). Qualitative research methods for the social sciences (7th ed.). Boston, MA: Allyn & Bacon.
  • Borg, M., & Kristiansen, K. (2004). Recovery oriented professionals: Helping relationships in mental health services. Journal of Mental Health, 13, 493–505. doi: 10.1080/09638230400006809
  • Burnard, P. (1996). Teaching the analysis of textual data: An experiential approach. Nurse Education Today, 16, 278–281. doi: 10.1016/S0260-6917(96)80115-8
  • Calsyn, R. J., Klinkenberg, W. D., Morse, G. A., & Lemming, M. R. (2006). Predictors of the working alliance in assertive community treatment. Community Mental Health Journal, 42, 161–175. doi: 10.1007/s10597-005-9022-7
  • Carrick, R., Mitchell, A., Powell, R. A., & Lloyd, K. (2004). The quest for well-being: A qualitative study of the experience of taking antipsychotic medication. Psychology and Psychotherapy: Theory, Research and Practice, 77, 19–33. doi: 10.1348/147608304322874236
  • Charles, C., Gafni, A., & Whelan, T. (1997). Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Social Science & Medicine, 44, 681–692. doi: 10.1016/S0277-9536(96)00221-3
  • Commonwealth of Australia. (2012). Mental health statement of rights and responsibilities 2012. Canberra: Canberra Department of Health and Ageing.
  • De Leeuw, M., Van Meijel, B., Grypdonck, M., & Kroon, H. (2012). The quality of the working alliance between chronic psychiatric patients and their case managers: Process and outcomes. Journal of Psychiatric and Mental Health Nursing, 19, 1–7. doi: 10.1111/j.1365-2850.2011.01741.x
  • Ende, J., Kazis, L., Ash, A., & Moskowitz, M. A. (1989). Measuring patients’ desire for autonomy: Decision making and information-seeking preferences among medical patients. Journal of General Internal Medicine, 4, 23–30. doi: 10.1007/BF02596485
  • Gray, R., Wykes, T., & Gournay, K. (2002). From compliance to concordance: A review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing, 9, 277–284. doi: 10.1046/j.1365-2850.2002.00474.x
  • Haddad, P. M., Brain, C., & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia: Challenges and management strategies. Patient Related Outcome Measures, 5, 43–62. doi: 10.2147/PROM.S42735
  • Halpern, J. (2003). Practicing medicine in the real world: Challenges to empathy and respect for patients. Journal of Clinical Ethics, 14, 298–307.
  • Hamer, H. P., Finlayson, M., & Warren, H. (2014). Insiders or outsiders? Mental health service users’ journeys towards full citizenship. International Journal of Mental Health Nursing, 23, 203–211. doi: 10.1111/inm.12046
  • Happell, B., Manias, E., & Roper, C. (2004). Wanting to be heard: Mental health consumers’ experiences of information about medication. International Journal of Mental Health Nursing, 13, 242–248. doi: 10.1111/j.1440-0979.2004.00340.x
  • Hartling, L., Abou-Setta, A. M., Dursun, S., Mousavi, S. S., Pasichnyk, D., & Newton, A. S. (2012). Antipsychotics in adults with schizophrenia: Comparative effectiveness of first-generation versus second-generation medications: A systematic review and meta-analysis. Annals of Internal Medicine, 157, 498–511. doi: 10.7326/0003-4819-157-7-201210020-00525
  • Hon, A. (2012). Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: Findings from a grounded theory study. Journal of Psychiatric and Mental Health Nursing, 19, 354–361. doi: 10.1111/j.1365-2850.2012.01898.x
  • Kikkert, M. J., Schene, A. H., Koeter, M. W., Robson, D., Born, A., Helm, H., & Gray, R. J. (2006). Medication adherence in schizophrenia: Exploring patients’, carers’ and professionals’ views. Schizophrenia Bulletin, 32, 786–794. doi: 10.1093/schbul/sbl011
  • Kvale, S., & Brinkmann, S. (2009). Interviews: Learning the craft of qualitative research interviewing (2nd ed.). Los Angeles: Sage.
  • Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14, 429–447. doi: 10.1038/sj.mp.4002136
  • Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A metaanalysis. Lancet, 373, 31–41. doi: 10.1016/S0140-6736(08)61764-X
  • Levinson, W., Lesser, C. S., & Epstein, R. M. (2010). Developing physician communication skills for patient-centered care. Health Affairs (Millwood), 29, 1310–1318. doi: 10.1377/hlthaff.2009.0450
  • McCabe, R., Heath, C., Burns, T., & Priebe, S. (2002). Engagement of patients with psychosis in the consultation: Conversation analytic study. British Medical Journal, 325, 1148–1151. doi: 10.1136/bmj.325.7373.1148
  • McCann, T. V., & Clark, E. (2004). Embodiment of severe and enduring mental illness: Finding meaning in schizophrenia. Issues in Mental Health Nursing, 25, 783–798. doi: 10.1080/01612840490506365
  • Meehan, T., Stedman, T., & Wallace, J. (2011). Consumer strategies for coping with antipsychotic medication side effects. Australasian Psychiatry, 19, 74–77. doi: 10.3109/10398562.2010.539612
  • Moncrieff, J., & Leo, J. (2010). A systematic review of the effects of antipsychotic drugs on brain volume. Psychological Medicine, 40, 1409–1422. doi: 10.1017/S0033291709992297
  • Morrison, P., Gaskill, D., Meehan, T., Lunney, P., Lawrence, G., & Collings, P. (2000). The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice. Australian and New Zealand Journal of Mental Health Nursing, 9, 166–176. doi: 10.1046/j.1440-0979.2000.00181.x
  • Morrison, P., Meehan, T., Gaskill, D., Lunney, P., & Collings, P. (2000). Enhancing case managers’ skills in the assessment and management of antipsychotic medication side-effects. Australian and New Zealand Journal of Psychiatry, 34, 814–821. doi: 10.1080/j.1440-1614.2000.00821.x
  • Morrison, P., Meehan, T., & Stomski, N. J. (2015a). Living with antipsychotic medication side effects: The experience of Australian mental health consumers. International Journal of Mental Health Nursing, 24, 253–261. doi: 10.1111/inm.12110
  • Morrison, P., Meehan, T., & Stomski, N. J. (2015b). Australian case managers’ perceptions of mental health consumers use of antipsychotic medications and associated side-effects. International Journal of Mental Health Nursing, 24, 104–111. doi: 10.1111/inm.12118
  • Morrison, P., & Stomski, N. J. (2015). Embracing participation in mental health research: Conducting authentic interviews. Qualitative Research Journal, 15, 47–60. doi: 10.1108/QRJ-05-2014-0021
  • Naber, D., Karow, A., & Lambert, M. (2005). Subjective well-being under the neuroleptic treatment and its relevance for compliance. ActaPsychiatriac Scandinavica Supplement, 111, 29–34. doi: 10.1111/j.1600-0447.2005.00542.x
  • Neale, M. S., & Rosenheck, R. A. (2000). Therapeutic limit setting in an assertive community treatment program. Psychiatric Services, 51, 499–505. doi: 10.1176/appi.ps.51.4.499
  • Peluso, M. J., Lewis, S. W., Barnes, T. R., & Jones, P. B. (2012). Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. British Journal of Psychiatry, 200, 387–392. doi: 10.1192/bjp.bp.111.101485
  • Prince, J. D. (2007). Therapeutic alliance, illness awareness, and number of hospitalizations for schizophrenia. Journal of Nervous and Mental Disorders, 195, 170–174. doi: 10.1097/01.nmd.0000253796.08183.52
  • Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009). Atypical antipsychotic drugs and the risk of sudden cardiac death. New England Journal of Medicine, 360, 225–235. doi: 10.1056/NEJMoa0806994
  • Rogers, A., Day, J., Randall, F., & Bentall, R. P. (2003). Patients’ understanding and participation in a trial designed to improve the management of anti-psychotic medication: A qualitative study. Social Psychiatry and Psychiatric Epidemiology, 38, 720–727. doi: 10.1007/s00127-003-0693-5
  • Rogers, A., Day, J. C., Williams, B., Randall, F., Wood, P., Healy, D., & Bentall, R. P. (1998). The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia. Social Science & Medicine, 47, 1313–1323. doi: 10.1016/S0277-9536(98)00209-3
  • Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Kissling, W., & Leucht, S. (2012). Second-generation antipsychotic drugs and extrapyramidal side effects: A systematic review and meta-analysis of head-to-head comparisons. Schizophrenia Bulletin, 38, 167–177. doi: 10.1093/schbul/sbq042
  • Sajatovic, M., Jenkins, J. H., Cassidy, K. A., & Muzina, D. J. (2009). Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar disorder. Journal of Affective Disorders, 115, 360–366. doi: 10.1016/j.jad.2008.10.002
  • Salomon, C., & Hamilton, B. (2013).  “All roads lead to medication?” Qualitative responses from an Australian first-person survey of antipsychotic discontinuation. Psychiaticr Rehabilitation Journal, 36, 160–165. doi: 10.1037/prj0000001
  • Schulze, B., & Angermeyer, M. C. (2003). Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Social Science & Medicine, 56, 299–312. doi: 10.1016/S0277-9536(02)00028-X
  • Seale, C., Chaplin, R., Lelliott, P., & Quirk, A. (2007). Antipsychotic medication, sedation and mental clouding: An observational study of psychiatric consultations. Social Science & Medicine, 65, 698–711. doi: 10.1016/j.socscimed.2007.03.047
  • Tranulis, C., Goff, D., Henderson, D. C., & Freudenreich, O. (2011). Becoming adherent to antipsychotics: A qualitative study of treatment-experienced schizophrenia patients. Psychiatric Services, 62, 888–892. doi: 10.1176/ps.62.8.pss6208_0888
  • Tuohy, D., Cooney, A., Dowling, M., Murphy, K., & Sixsmith, J. (2013). An overview of interpretive phenomenology as a research methodology. Nurse Researcher, 20,17–20. doi: 10.7748/nr2013.07.20.6.17.e315
  • Usher, K., Park, T., & Foster, K. (2013). The experience of weight gain as a result of taking second-generation antipsychotic medications: the mental health consumer perspective. Journal of Psychiatric and Mental Health Nursing, 20, 801–806.
  • Vandyk, A. D., & Baker, C. (2012). Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain. International Journal of Mental Health Nursing, 21, 349–357. doi: 10.1111/j.1447-0349.2011.00790.x
  • Ware, N. C., Tugenberg, T., & Dickey, B. (2004). Practitioner relationships and quality of care for low-income persons with serious mental illness. Psychiatric Services, 55, 555–559. doi: 10.1176/appi.ps.55.5.555
  • Woltmann, E. M., & Whitley, R. (2010). Shared decision making in public mental health care: Perspectives from consumers living with severe mental illness. Psychiatric Rehabilitation Journal, 34, 29–36. doi: 10.2975/34.1.2010.29.36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.